Provided by Tiger Trade Technology Pte. Ltd.

Celldex Therapeutics

29.30
-1.1300-3.71%
Post-market: 29.15-0.1500-0.51%19:30 EDT
Volume:3.95M
Turnover:115.44M
Market Cap:2.30B
PE:-6.75
High:30.10
Open:30.07
Low:28.63
Close:30.43
52wk High:45.14
52wk Low:22.10
Shares:78.49M
Float Shares:73.02M
Volume Ratio:2.29
T/O Rate:5.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3401
EPS(LYR):-3.9000
ROE:-43.88%
ROA:-27.62%
PB:3.22
PE(LYR):-7.51

Loading ...

Celldex’s barzolvolimab meets endpoints in Phase 3 urticaria trial

TIPRANKS
·
Sep 22

Celldex Says Barzolvolimab Meets Primary Endpoint in Phase 3 Embarq-CSU Studies for Chronic Spontaneous Urticaria

Reuters
·
Sep 22

Celldex Announces Positive Results from Phase 3 Embarq-Csu1 and Embarq-Csu2 Studies of Barzolvolimab Which Met Primary and All Key Secondary Endpoints

THOMSON REUTERS
·
Sep 22

Celldex Therapeutics, - Barzolvolimab Well-Tolerated with Favorable Safety Profile Through 24 Weeks

THOMSON REUTERS
·
Sep 22

Celldex Therapeutics, - Phase 3 Trials Met Primary and All Key Secondary Endpoints at Week 12

THOMSON REUTERS
·
Sep 22

Celldex Therapeutics, - Treatment to Continue to 52 Weeks; Bla Submission Planned for 2027

THOMSON REUTERS
·
Sep 22

Celldex Announces Positive Results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 Studies of Barzolvolimab Which Met Primary and All Key Secondary Endpoints

GlobeNewswire
·
Sep 22

Barzolvolimab’s Strong CSU Prospects Lead Sam Slutsky to Reaffirm Buy on CLDX with Unchanged $56 Price Target

TIPRANKS
·
Sep 21

Analysts Are Bullish on These Healthcare Stocks: Immunic (IMUX), Celldex (CLDX)

TIPRANKS
·
Sep 10

Celldex Therapeutics Inc : Morgan Stanley Raises Target Price to $50.00 from $46.00

THOMSON REUTERS
·
Sep 10

U.S. Research Roundup-Caseys General Stores, Targa Resources, United Rentals

Reuters
·
Sep 10

Celldex Management to Join Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Sep 09

Celldex Posts Investor Presentation Highlighting Barzolvolimab Late-Stage Chronic Urticaria Program Milestones

Reuters
·
Aug 15

Celldex Therapeutics (CLDX) Reported Wider Losses, Is It Still Undervalued?

Simply Wall St.
·
Aug 12

Celldex (CLDX) Gets a Buy from Jefferies

TIPRANKS
·
Aug 08

Celldex Therapeutics is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Aug 08

Analysts Offer Insights on Healthcare Companies: Zoetis (ZTS) and Celldex (CLDX)

TIPRANKS
·
Aug 08

Celldex price target raised to $46 from $40 at Morgan Stanley

TIPRANKS
·
Aug 07

Celldex Therapeutics Q2 EPS $(0.94) Beats $(1.07) Estimate, Sales $22.000K Miss $954.444K Estimate

Benzinga Earnings
·
Aug 07

Celldex Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07